quinazolines has been researched along with Acoustic Neuroma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, JC; Hagiwara, M; Hu, J; Karajannis, MA; Mitchell, C; Osorio, DS; Stanek, J | 1 |
| Clark, JJ; Diggelmann, HR; Hansen, MR; Hansen, SS; Provenzano, M; Xu, N | 1 |
| Allen, JC; Ammoun, S; Chiriboga, L; Cunliffe, CH; Giancotti, FG; Hanemann, CO; Karajannis, MA; Zagzag, D | 1 |
| Barker, FG; Batchelor, TT; Halpin, C; Loeffler, JS; McKenna, MJ; Plotkin, SR | 1 |
| Ahmad, ZK; Brown, CM; Cueva, RA; Doherty, JK; Ryan, AF | 1 |
| Burns, SS; Bush, ML; Chang, LS; Davletova, S; Jacob, A; Oblinger, J; Welling, DB | 1 |
| Plotkin, SR; Terry, AR | 1 |
| Allen, JC; Ballas, MS; Brown, K; Goldberg, JD; Golfinos, JG; Hagiwara, M; Hochman, T; Karajannis, MA; Koch, KM; Legault, G; Nusbaum, AO; Roland, JT | 1 |
1 review(s) available for quinazolines and Acoustic Neuroma
| Article | Year |
|---|---|
Chemotherapy: present and future.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials, Phase II as Topic; ErbB Receptors; Erlotinib Hydrochloride; Evidence-Based Medicine; Female; Follow-Up Studies; Forecasting; Humans; Magnetic Resonance Imaging; Male; Molecular Targeted Therapy; Neurofibromatosis 2; Neuroma, Acoustic; Quinazolines; Radiosurgery; Risk Assessment; Treatment Outcome | 2012 |
2 trial(s) available for quinazolines and Acoustic Neuroma
| Article | Year |
|---|---|
Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2.
Topics: Adult; Antineoplastic Agents; Female; Humans; Imaging, Three-Dimensional; Lapatinib; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neurofibromatosis 2; Neuroma, Acoustic; Quinazolines; Retrospective Studies; Young Adult | 2018 |
Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Lapatinib; Magnetic Resonance Imaging; Male; Middle Aged; Neurofibromatosis 2; Neuroma, Acoustic; Prognosis; Prospective Studies; Quinazolines; Survival Rate; Tissue Distribution; Young Adult | 2012 |
5 other study(ies) available for quinazolines and Acoustic Neuroma
| Article | Year |
|---|---|
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Death; Cell Proliferation; Erlotinib Hydrochloride; Fluorescent Antibody Technique; Genes, erbB; Magnetic Resonance Imaging; Mice; Mice, Nude; Neuroma, Acoustic; Protein Kinase Inhibitors; Quinazolines; Trastuzumab | 2008 |
ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Survival; ErbB Receptors; Humans; Immunohistochemistry; Lapatinib; Mitogen-Activated Protein Kinases; Neuroma, Acoustic; Protein Array Analysis; Quinazolines; Receptor, ErbB-2; Signal Transduction | 2010 |
Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.
Topics: Adolescent; Adult; Antineoplastic Agents; Audiometry, Pure-Tone; Disease Progression; Erlotinib Hydrochloride; Female; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurofibromatosis 2; Neuroma, Acoustic; Quinazolines; Speech Perception; Treatment Outcome; Young Adult | 2010 |
ErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas.
Topics: Benzothiazoles; Cell Cycle; Cell Proliferation; Epidermal Growth Factor; Humans; Lapatinib; Neuroma, Acoustic; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Signal Transduction; Tumor Cells, Cultured; Tyrphostins | 2011 |
Treatment of vestibular schwannoma cells with ErbB inhibitors.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Ear Neoplasms; Erlotinib Hydrochloride; Humans; Immunohistochemistry; Lapatinib; Neuroma, Acoustic; Oncogene Proteins v-erbB; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Vestibular Nerve | 2012 |